Chlamydial pneumonia

Chlamydial pneumonia is a bacterial pneumonia associated in the cited materials with Chlamydia trachomatis infection and neonatal transmission during the birth process ^[1]. The source set identifies it as a recognized clinical entity in pediatric and neonatal reference materials, but does not provide a detailed etiologic taxonomy or strain-specific characterization beyond this association ^[3][4][5]. Source-backed detail on incubation, chronicity, or broader species range is not yet available ^[2][1].

In the neonatal literature provided, chlamydial infection can present with pneumonia and may coexist with inclusion conjunctivitis, indicating multi-site disease in early life ^[1]. The Botswana case series also notes infants with signs suggestive of chlamydial pneumonia at presentation among cases of chlamydial ophthalmia neonatorum ^[6]. No source-backed detail is available here on the typical respiratory symptom pattern, radiographic findings, age at onset, or complications outside the newborn period ^[2][1][6]. The cited neonatal source states that reported mortality was absent in that context, while morbidity was high ^[1].

The evidence provided emphasizes neonatal disease acquired from mothers with perinatal chlamydia infection, including cases observed in an antenatal-clinic study population in Gaborone, Botswana ^[1][6]. One source notes that Chlamydia trachomatis infections are the most prevalent of all sexually transmitted diseases, which frames the broader infection ecology relevant to neonatal exposure ^[1]. However, source-backed detail on the geographic distribution of chlamydial pneumonia itself, community incidence, seasonality, or outbreak behavior is not yet available ^[3][4][2]. The surveillance materials available here suggest that chlamydial pneumonia should be interpreted as part of a perinatal sexually transmitted infection burden rather than as a stand-alone respiratory outbreak signal ^[1][6].

The provided sources indicate transmission to the neonate during the birth process, linking disease occurrence to maternal chlamydial infection around the time of delivery ^[1]. In the Botswana series, infants born to mothers with postnatal or perinatal C. trachomatis infection were evaluated for neonatal chlamydial disease, reinforcing vertical or peripartum exposure as the relevant route in these materials ^[6]. No source-backed evidence here describes respiratory-to-respiratory spread, environmental persistence, or other transmission pathways ^[2][1][6].

The clearest source-supported risk group is neonates exposed during birth to maternal Chlamydia trachomatis infection ^[1]. The Botswana series further indicates infants born to mothers with perinatal or postnatal infection as the population in which neonatal chlamydial disease, including possible pneumonia, was identified ^[6]. No additional source-backed high-risk categories are specified in the provided snippets ^[2][1][6].

Prevention in the provided material centers on neonatal and maternal care, including prevention, early detection, and management of neonatal chlamydial infection ^[1]. The Botswana report notes that most infants had received ocular 1% tetracycline prophylaxis at birth, yet cases still occurred, suggesting that the sources view current prophylaxis as insufficient in that setting ^[6]. Beyond these observations, source-backed detail on maternal screening protocols, treatment timing, or alternative preventive strategies is not yet available ^[1][6].

For surveillance purposes, this condition should be read as a neonatal chlamydial disease signal that may appear alongside conjunctivitis and perinatal maternal infection, rather than as an isolated pneumonia code with abundant standalone epidemiologic data ^[1][6]. The source set is limited and includes review citations and scholarly metadata, so findings should be interpreted cautiously and as evidence of recognized clinical use rather than as a complete burden estimate ^[3][4][2]. Source-backed detail on thresholds, standard case definitions, or trend interpretation is not yet available ^[2][1][6].

1. 1 Hess DL et al. Chlamydia in the neonate. Neonatal Netw. 1993 Apr. PMID: 8474419. PubMed: https://pubmed.ncbi.nlm.nih.gov/8474419/
2. 2 Kishimoto T et al. [Chlamydial pneumonia]. Nihon Rinsho. 2007 Mar 28. PMID: 17494169. PubMed: https://pubmed.ncbi.nlm.nih.gov/17494169/
3. 3 Infant chlamydial pneumonia. BMJ. 1983. doi: 10.1136/bmj.286.6382.1979. DOI: https://doi.org/10.1136/bmj.286.6382.1979
4. 4 Chlamydial Pneumonia. Pediatric Pulmonology, Asthma, and Sleep Medicine: A Quick Reference Guide. 2018. doi: 10.1542/9781610021432-part04-ch57. DOI: https://doi.org/10.1542/9781610021432-part04-ch57
5. 5 Pneumonia: Chlamydial. The APRN and PA’s Complete Guide to Prescribing Drug Therapy. 2019. doi: 10.1891/9780826179357.0304. DOI: https://doi.org/10.1891/9780826179357.0304
6. 6 Yang K et al. Case series and literature review of chlamydial ophthalmia neonatorum in Botswana. Int J STD AIDS. 2023 Oct. PMID: 37338101. doi: 10.1177/09564624231173028. PubMed: https://pubmed.ncbi.nlm.nih.gov/37338101/

ICD-10

ICD-11

Total cases

3K

Peak month

2012-12

Coverage

1 reporting countries · 2012-09-15 → 2026-06-20